AB054
AB054 is a humanized monoclonal antibody targeting factor XII (FXII). AB054 inhibits FXII activation and FXIIa activity through specific binding to the catalytic domain of FXII, and exerts antithrombotic effects in a concentration-dependent manner. AB054 can be used in studies related to thrombosis.
Para uso exclusivo en investigación. No vendemos a pacientes.
-
Almacenamiento:
Please store the product under the recommended conditions in the Certificate of Analysis.
Actividad biológica
Human
AB054 (0-100 μg/mL; 5 min) significantly prolongs the aPTT of human plasma and baboon plasma in a concentration-dependent manner[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:Baboons (juvenile male, 9~15kg, with healed surgically implanted chronic arteriovenous shunt device)[1]
-
Dosage:5 mg/kg (single agent); 2 mg/kg (plus 5 mg/kg 24h prior, in combination with 20 U/kg heparin)
-
Administration:i.v. bolus; 30 min before experiment (AB054); 15 min before experiment (heparin)
-
Result:Reduced platelet deposition rate, terminal platelet deposition, and terminal fibrin content in.
Maintained hemostatic parameters (bleeding time, blood loss, bleeding rate) within normal baboon ranges across all treatment groups.
F12/Factor XII
Unconjugated
The product can be reconstituted/diluted with sterile PBS or saline.
-
Product Image
ELISA, FACS, Functional assay
Chemical Information
-
SMILES
[AB054]
-
Formulation
Please refer to the lot-specific COA for specific buffer information.
-
Almacenamiento
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureza y Documentación
Referencias
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)